NASDAQ:NGEN

NervGen Stock Climbs with Trial Approaching, Cash Burn Still a Focus
····

NervGen Stock Climbs with Trial Approaching, Cash Burn Still a Focus

NervGen Pharma shares climbed nearly 4% to $3.70 on Nasdaq after the company announced it had reached agreement with the FDA to begin its late-stage RESTORE trial for NVG-291 in chronic tetraplegia. The company reported C$16.56 million in cash at March 31, enough to fund operations through Q2 2026, and said additional capital will be needed for the Phase 3 trial.
May 20, 2026

Stock Market Today

  • Cattle Prices Surge with Rainfall Boost in Australian Markets
    May 30, 2026, 2:16 AM EDT. Cattle prices in Australia have seen significant increases this week due to rainfall in key production areas, especially New South Wales. The Meat and Livestock Australia (MLA) Eastern Young Cattle Indicator (EYCI) reached its highest level since 2022, with prices rising up to 100 cents per kilogram in some saleyards. Heavy cow prices hit record highs, with saleyard prices exceeding $4.20/kg and a record $4.42/kg at Dalby. Meanwhile, Australian abattoirs processed a weekly record of 166,446 head, supporting expectations for a record beef production in 2026. Grain prices fell slightly as rain improved winter crop outlooks, benefiting feedlots now managing a record 1.62 million head of cattle on feed, reflecting continued sector confidence amid global market uncertainties.